Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Primary Immunodeficiency Diseases in Covid-19 Pandemic: A Predisposing or Protective Factor? Publisher Pubmed



Babaha F1, 2 ; Rezaei N1, 2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Iran
  2. 2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  3. 3. Department of Immunology, School of Medicine, Children's Medical Center Hospital, Tehran University of Medical Sciences, Dr. Qarib St, Keshavarz Blvd, 14194, Tehran, Iran

Source: American Journal of the Medical Sciences Published:2020


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. A Systematic Review of Pregnant Women With Covid-19 and Their Neonates, Archives of Gynecology and Obstetrics (2021)
2. Computed Tomography Scan in Covid-19: A Systematic Review and Meta-Analysis, Polish Journal of Radiology (2022)
3. Altered Immunoemotional Regulatory System in Covid-19: From the Origins to Opportunities, Journal of Neuroimmunology (2021)
4. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)
5. Health Care Policies and Covid-19 Prevalence: Is There Any Association?, International Journal of Health Services (2022)
6. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
7. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
8. Exploration of the Epidemiological and Emotional Impact of Quarantine and Isolation During the Covid-19 Pandemic, Advances in Experimental Medicine and Biology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (80)
Mohammadreza Salehi (7)
Other Related Docs
9. Biosensing Surfaces and Therapeutic Biomaterials for the Central Nervous System in Covid-19, Emergent Materials (2021)
10. Computational Drug Discovery and Repurposing for the Treatment of Covid-19: A Systematic Review, Bioorganic Chemistry (2021)
11. Microfluidic Devices for Detection of Rna Viruses, Reviews in Medical Virology (2021)
12. Health and Art (Heart): Integrating Science and Art to Fight Covid-19, Advances in Experimental Medicine and Biology (2021)
13. Dysregulation of the Immune Response in Coronavirus Disease 2019, Cell Biology International (2021)
14. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
15. Cytokine Release Syndrome: Inhibition of Pro-Inflammatory Cytokines As a Solution for Reducing Covid-19 Mortality, European Cytokine Network (2020)
16. Interferon Therapy in Patients With Sars, Mers, and Covid-19: A Systematic Review and Meta-Analysis of Clinical Studies, European Journal of Pharmacology (2021)
17. Neurologic Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
18. Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in Covid-19: A Multisystem Disease, Advances in Experimental Medicine and Biology (2021)
19. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
20. Serological Tests for Covid-19: Potential Opportunities, Cell Biology International (2021)
21. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
22. Anosmia: A Missing Link in the Neuroimmunology of Coronavirus Disease 2019 (Covid-19), Reviews in the Neurosciences (2020)
23. Immunotherapy for Sars-Cov-2: Potential Opportunities, Expert Opinion on Biological Therapy (2020)
24. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
25. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)
26. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
27. How Covid-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment, Advances in Experimental Medicine and Biology (2021)
28. Covid-19 in Patients With Cancer, Advances in Experimental Medicine and Biology (2021)
29. Interdisciplinary Approaches to Covid-19, Advances in Experimental Medicine and Biology (2021)
30. Cytokines and Covid-19: Friends or Foes?, Human Vaccines and Immunotherapeutics (2020)
31. A Borderless Solution Is Needed for a Borderless Complexity, Like Covid-19, the Universal Invader, Advances in Experimental Medicine and Biology (2021)
32. How Prevalent Is Cancer in Confirmed Cases With Coronaviruses and Severe Acute Respiratory Syndromes?, Advances in Experimental Medicine and Biology (2021)
33. Covid-19 and Its Global Economic Impact, Advances in Experimental Medicine and Biology (2021)
34. Angiotensin-Converting Enzyme 2 (Ace2) Receptor and Sars-Cov-2: Potential Therapeutic Targeting, European Journal of Pharmacology (2020)
35. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
36. Lymphopenia in Covid-19: Therapeutic Opportunities, Cell Biology International (2020)
37. The Role of Angiotensin-Converting Enzyme 2 in Covid-19 Induced Lung Injury, Acta Biomedica (2020)
38. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
39. Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19, Allergy# Asthma and Clinical Immunology (2021)
40. Regenerative Medicine in Covid-19 Treatment: Real Opportunities and Range of Promises, Stem Cell Reviews and Reports (2021)
41. The Immune System and Covid-19: Friend or Foe?, Life Sciences (2020)
42. Nutrition and Immunity in Covid-19, Advances in Experimental Medicine and Biology (2021)
43. Covid-19 in a Child With Primary Antibody Deficiency, Clinical Case Reports (2021)
44. Anti-Ige Monoclonal Antibodies As Potential Treatment in Covid-19, Immunopharmacology and Immunotoxicology (2021)
45. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the Sars-Cov-2 Cytokine Storm, Current Pharmaceutical Design (2021)
46. Dynamic Antibody Response: A Biomarker for Covid-19, Clinical Laboratory (2021)
47. Death Due to Covid-19 in a Patient With Diabetes, Epilepsy, and Gout Comorbidities, Clinical Case Reports (2020)
48. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
49. Socialization During the Covid-19 Pandemic: The Role of Social and Scientific Networks During Social Distancing, Advances in Experimental Medicine and Biology (2021)
50. Autoimmune Complications of Covid-19, Journal of Medical Virology (2022)